Clinical trial
Thromboelastography As A Tool for Possible Clopidogrel Resistance in The Patients Treated With Primary PCI for STEMI
NCT00517478 is registered in ClinicalTrials.gov with Assaf-Harofeh Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thromboelastography As A Tool for Possible Clopidogrel Resistance in The Patients Treated With Primary PCI for STEMI
- Lead sponsor
- Assaf-Harofeh Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 31, 2007
- Completion date
- February 29, 2008
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease, myocardial infarction